Gary Phillips – CEO – Syntara (ASX:SNT) is a clinical-stage drug development company working to bring new and life-changing treatments to patients in need. The company has ongoing trials in myelofibrosis, myelodysplastic syndrome, scar prevention, modifcation of existing scars, isolated REM sleep behaviours disorder and Parkinson’s Disease.
Syntara (ASX:SNT) – Webinar Presentation Read More »
Perennial Partners Portfolio Manager and Resources Analyst Sam Berridge discusses the outlook for resources.
The outlook for resources, May 2024 Read More »
Glenn Corrie – CEO & Managing Director – Hazer Group Limited (ASX:HZR) is commercialising a low-emission hydrogen and graphite production process. Natural gas and similar feedstocks are converted into hydrogen and graphite, using iron ore as a catalyst.
Hazer Group (ASX:HZR) – Webinar Presentation Read More »
Adrian Floate – Managing & Executive Director – Spenda Limited (ASX:SPX) is an integrated payments and lending platform supplying industries with a broad range of B2B payment services, digital trading software and integrated solutions.
Spenda (ASX:SPX) – Webinar Presentation Read More »
Elementos (ASX:ELT) has commenced diamond drilling at its 100% owned Cleveland Tin Project, located near Waratah in Tasmania. The drilling operation, spanning 1,100 meters, aims to investigate mineralization of tin, copper, tungsten, and fluorite. This initiative builds upon the company’s previously published Ore Reserves, Mineral Resources, and Exploration Target. The drill hole, positioned with a
Elementos initiates diamond drilling at Cleveland Tin Project Read More »
Disclaimer: Sequoia Financial Group (ASX:SEQ), the parent company of Finance News Network, owns a 20 per cent interest in Euree Asset Management.
Winston’s Weekly: Inflation, RBA and budget Read More »
Oil prices remained relatively stable throughout the week, with Brent trading slightly above $83 a barrel and West Texas Intermediate below $80, as the market focused on supply dynamics and inflation concerns. Despite lower US crude inventories and indications of easing inflation, conflicting reports on demand growth from organizations like the International Energy Agency contributed
ASX down 0.42% near noon: Oil prices stabilise Read More »
Talk about a brave move—President Biden’s attack on the Chinese electric vehicle markets is nothing but a load of hot air; real Alice Through the Looking Glass material. Putting tariffs on something that is not there will have no impact whatsoever. Chinese export data shows that few, if any, electric vehicles have been exported to
Biden hits Chinese EVs Read More »
Warren Buffett’s $US6.7 billion move into the smaller insurer Chubb, controlled by a long-time family friend, dominated this week’s final quarterly data drop from the world’s most followed investor. Safe to say, the new investment is what investors focused on. It wasn’t as dramatic as some investors had wanted, nor was it a ‘control’ plunge
Why Chubb was on Buffett’s buffet Read More »
To register for today’s webinar click here. PharmAust (ASX:PAA & PAAOA) announced it has received Orphan Drug Designation (ODD) from the United States Food and Drug Administration for monepantel and its treatment of Motor Neurone Disease (MND). PharmAust’s application was based on preclinical mechanistic data that demonstrates MPL can induce autophagy in diseased cells, and
Stocks of the Hour: PharmAust, Impact Minerals, Peregrine Gold Read More »
